Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Page 1
Adjunct prednisone in community-acquired pneumonia: 180-day outcome of a multicentre, double-blind, randomized, placebo-controlled trial.
Blum CA, Roethlisberger EA, Cesana-Nigro N, Winzeler B, Rodondi N, Blum MR, Briel M, Mueller B, Christ-Crain M, Schuetz P. Blum CA, et al. Among authors: briel m. BMC Pulm Med. 2023 Dec 11;23(1):500. doi: 10.1186/s12890-023-02794-w. BMC Pulm Med. 2023. PMID: 38082273 Free PMC article. Clinical Trial.
BACKGROUND: Several trials and meta-analyses found a benefit of adjunct corticosteroids for community-acquired pneumonia with respect to short-term outcome, but there is uncertainty about longer-term health effects. Herein, we evaluated clinical outcomes at long …
BACKGROUND: Several trials and meta-analyses found a benefit of adjunct corticosteroids for community-acquired pneumonia with respect to sho …
Towards the development of a comprehensive framework: Qualitative systematic survey of definitions of clinical research quality.
von Niederhäusern B, Schandelmaier S, Mi Bonde M, Brunner N, Hemkens LG, Rutquist M, Bhatnagar N, Guyatt GH, Pauli-Magnus C, Briel M. von Niederhäusern B, et al. Among authors: briel m. PLoS One. 2017 Jul 17;12(7):e0180635. doi: 10.1371/journal.pone.0180635. eCollection 2017. PLoS One. 2017. PMID: 28715491 Free PMC article.
RESULTS: Stakeholder concepts on how to assure quality throughout study conduct or articles on quality assessment tools were common, generally with no a priori definition of the term quality itself. We identified a total of 20 explicit definitions of clinical research qual …
RESULTS: Stakeholder concepts on how to assure quality throughout study conduct or articles on quality assessment tools were common, general …
Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study.
Odermatt J, Meili M, Hersberger L, Bolliger R, Christ-Crain M, Briel M, Bucher HC, Mueller B, Schuetz P. Odermatt J, et al. Among authors: briel m. BMC Cardiovasc Disord. 2017 Jul 4;17(1):178. doi: 10.1186/s12872-017-0605-3. BMC Cardiovasc Disord. 2017. PMID: 28676115 Free PMC article.
BACKGROUND: Several studies found mid-regional pro-adrenomedullin (ProADM), the prohormone of the cardiovascular protein adrenomedullin, to be strongly associated with short-term mortality, mostly in the inpatient setting. We evaluated associations of ProADM levels with 10 …
BACKGROUND: Several studies found mid-regional pro-adrenomedullin (ProADM), the prohormone of the cardiovascular protein adrenomedullin, to …
The natriuretic peptide MR-proANP predicts all-cause mortality and adverse outcome in community patients: a 10-year follow-up study.
Odermatt J, Hersberger L, Bolliger R, Graedel L, Christ-Crain M, Briel M, Bucher HC, Mueller B, Schuetz P. Odermatt J, et al. Among authors: briel m. Clin Chem Lab Med. 2017 Aug 28;55(9):1407-1416. doi: 10.1515/cclm-2016-0760. Clin Chem Lab Med. 2017. PMID: 28107168 Free article.
Little is known about the prognostic potential of this peptide for long-term mortality prediction in community-dwelling patients. We evaluated associations of MR-proANP levels with 10-year all-cause mortality in patients visiting their general practitioner for a respirator …
Little is known about the prognostic potential of this peptide for long-term mortality prediction in community-dwelling patients. We …
Colchicine and Prevention of Cardiovascular Events.
Hemkens LG, Ewald H, Briel M. Hemkens LG, et al. Among authors: briel m. JAMA. 2016 Sep 13;316(10):1106-7. doi: 10.1001/jama.2016.11044. JAMA. 2016. PMID: 27623465
CLINICAL QUESTION: Is continuous long-term treatment with colchicine associated with lower rates of all-cause mortality and myocardial infarction and higher rates of adverse events? BOTTOM LINE: Continuous long-term treatment with colchicine may be associated with l …
CLINICAL QUESTION: Is continuous long-term treatment with colchicine associated with lower rates of all-cause mortality and myocardia …
Colchicine for prevention of cardiovascular events.
Hemkens LG, Ewald H, Gloy VL, Arpagaus A, Olu KK, Nidorf M, Glinz D, Nordmann AJ, Briel M. Hemkens LG, et al. Among authors: briel m. Cochrane Database Syst Rev. 2016 Jan 27;2016(1):CD011047. doi: 10.1002/14651858.CD011047.pub2. Cochrane Database Syst Rev. 2016. PMID: 26816301 Free PMC article. Review.
OBJECTIVES: To evaluate potential cardiovascular benefits and harms of a continuous long-term treatment with colchicine in any population, and specifically in people with high cardiovascular risk. ...
OBJECTIVES: To evaluate potential cardiovascular benefits and harms of a continuous long-term treatment with colchicine in any popula …
Bias in dissemination of clinical research findings: structured OPEN framework of what, who and why, based on literature review and expert consensus.
Bassler D, Mueller KF, Briel M, Kleijnen J, Marusic A, Wager E, Antes G, von Elm E, Altman DG, Meerpohl JJ; OPEN Consortium. Bassler D, et al. Among authors: briel m. BMJ Open. 2016 Jan 21;6(1):e010024. doi: 10.1136/bmjopen-2015-010024. BMJ Open. 2016. PMID: 26801469 Free PMC article. Review.
SETTING: We performed a scoping review of definitions of the term 'publication bias' in highly cited publications. PARTICIPANTS: Ideas and experiences of a core group of authors were collected in a draft document, which was complemented by the findings from our literature …
SETTING: We performed a scoping review of definitions of the term 'publication bias' in highly cited publications. PARTICIPANTS: Idea …
Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial.
Blum CA, Nigro N, Briel M, Schuetz P, Ullmer E, Suter-Widmer I, Winzeler B, Bingisser R, Elsaesser H, Drozdov D, Arici B, Urwyler SA, Refardt J, Tarr P, Wirz S, Thomann R, Baumgartner C, Duplain H, Burki D, Zimmerli W, Rodondi N, Mueller B, Christ-Crain M. Blum CA, et al. Among authors: briel m. Lancet. 2015 Apr 18;385(9977):1511-8. doi: 10.1016/S0140-6736(14)62447-8. Epub 2015 Jan 19. Lancet. 2015. PMID: 25608756 Clinical Trial.
BACKGROUND: Clinical trials yielded conflicting data about the benefit of adding systemic corticosteroids for treatment of community-acquired pneumonia. We assessed whether short-term corticosteroid treatment reduces time to clinical stability in patients admitted to hospi …
BACKGROUND: Clinical trials yielded conflicting data about the benefit of adding systemic corticosteroids for treatment of community-acquire …
Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial.
Marincek N, Radojewski P, Dumont RA, Brunner P, Müller-Brand J, Maecke HR, Briel M, Walter MA. Marincek N, et al. Among authors: briel m. J Nucl Med. 2015 Feb;56(2):171-6. doi: 10.2967/jnumed.114.147256. Epub 2015 Jan 15. J Nucl Med. 2015. PMID: 25593116 Free article. Clinical Trial.
Meningiomas express members of the somatostatin receptor family. The present study assessed the long-term benefits and harm of somatostatin-based radiopeptide therapy in meningioma patients. ...
Meningiomas express members of the somatostatin receptor family. The present study assessed the long-term benefits and harm of somato …
23 results